Qi Zheng

1.2k total citations
64 papers, 802 citations indexed

About

Qi Zheng is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Qi Zheng has authored 64 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 21 papers in Hepatology and 17 papers in Surgery. Recurrent topics in Qi Zheng's work include Liver Disease Diagnosis and Treatment (23 papers), Hepatitis B Virus Studies (21 papers) and Hepatitis C virus research (17 papers). Qi Zheng is often cited by papers focused on Liver Disease Diagnosis and Treatment (23 papers), Hepatitis B Virus Studies (21 papers) and Hepatitis C virus research (17 papers). Qi Zheng collaborates with scholars based in China and United States. Qi Zheng's co-authors include Hylton R. Mayer, Ron A. Adelman, Yueyong Zhu, Jiaji Jiang, Christopher D Stave, Mindie H. Nguyen, Biyao Zou, Ramsey Cheung, Yuankai Wu and Runping Liu and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Journal of Controlled Release.

In The Last Decade

Qi Zheng

60 papers receiving 782 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qi Zheng China 18 340 190 180 135 110 64 802
Mohamed Egypt 13 200 0.6× 180 0.9× 102 0.6× 13 0.1× 93 0.8× 58 604
Shijie Zhang China 17 94 0.3× 64 0.3× 327 1.8× 11 0.1× 180 1.6× 70 831
Sethuraman Swaminathan United States 14 171 0.5× 12 0.1× 114 0.6× 30 0.2× 110 1.0× 47 528
Shigeki Tsukada United States 6 282 0.8× 374 2.0× 168 0.9× 5 0.0× 100 0.9× 7 585
Lilong Zhang China 16 148 0.4× 65 0.3× 271 1.5× 7 0.1× 141 1.3× 53 790
Alireza Sadeghipour Iran 16 83 0.2× 12 0.1× 95 0.5× 60 0.4× 136 1.2× 66 695
Zahra Mirfeizi Iran 13 77 0.2× 26 0.1× 95 0.5× 38 0.3× 51 0.5× 64 583
Jin Ha Lee South Korea 16 209 0.6× 75 0.4× 377 2.1× 22 0.2× 147 1.3× 29 837
Kazuo Yoneyama Japan 15 99 0.3× 113 0.6× 140 0.8× 7 0.1× 153 1.4× 43 580

Countries citing papers authored by Qi Zheng

Since Specialization
Citations

This map shows the geographic impact of Qi Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Zheng more than expected).

Fields of papers citing papers by Qi Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Zheng. The network helps show where Qi Zheng may publish in the future.

Co-authorship network of co-authors of Qi Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Qi Zheng. A scholar is included among the top collaborators of Qi Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi Zheng. Qi Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Y., Xiaolong Qiu, Yujie Xu, et al.. (2025). Long-term effectiveness and safety of baricitinib treatment on refractory or severe juvenile dermatomyositis. Lara D. Veeken. 64(9). 4948–4956. 2 indexed citations
2.
Yao, Tony, et al.. (2025). A “Janus” structured nanoclay microgel system for targeted probiotic therapy in diarrhea-predominant irritable bowel syndrome. Journal of Controlled Release. 383. 113769–113769. 3 indexed citations
4.
Zhang, Ying, et al.. (2024). Systematic review with network meta-analysis: sustained hepatitis B surface antigen clearance after pegylated interferon cessation. European Journal of Gastroenterology & Hepatology. 36(10). 1159–1170. 1 indexed citations
5.
Chen, Wei, et al.. (2024). HRAS Induces Ferroptosis through Upregulating HSPB1 in Hepatocellular Carcinoma. Combinatorial Chemistry & High Throughput Screening. 28(14). 2502–2510. 2 indexed citations
6.
Zheng, Qi, Xueping Yu, Airong Hu, et al.. (2024). Determining optimal ALT cut‐off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection. Alimentary Pharmacology & Therapeutics. 59(5). 692–704. 1 indexed citations
8.
Wang, Jian, Rui Huang, Jiacheng Liu, et al.. (2023). A novel non‐invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD. Journal of Viral Hepatitis. 30(4). 287–296. 5 indexed citations
10.
Ye, Xiang‐Yang, Hui‐Ming Lin, Shuo Lin, et al.. (2023). Development a novel nomogram model for predicting significant hepatic histological changes in chronic hepatitis B virus carriers. Journal of Medical Virology. 95(7). e28943–e28943. 2 indexed citations
11.
Lin, Shan, Miaomiao Wang, Na Li, et al.. (2023). Tenofovir alafenamide significantly increased serum lipid levels compared with entecavir therapy in chronic hepatitis B virus patients. World Journal of Hepatology. 15(8). 964–972. 8 indexed citations
12.
Rui, Jia, et al.. (2018). Coexistence of myasthenia gravis and Lambert–Eaton myasthenic syndrome in a small cell lung cancer patient. Medicine. 97(23). e10976–e10976. 5 indexed citations
13.
Chen, Yanmin, Yin Bai, Xiaochen Guo, et al.. (2016). Selection of affinity-improved neutralizing human scFv against HBV PreS1 from CDR3 VH/VL mutant library. Biologicals. 44(4). 271–275. 2 indexed citations
14.
Guo, Minggao, et al.. (2015). Focused parathyroidectomy through an open‐lateral approach for treating solitary parathyroid adenoma. Surgical Practice. 19(4). 160–165. 1 indexed citations
15.
Liu, Yurong, et al.. (2015). Serum HBsAg and HBeAg levels are associated with liver pathological stages in the immune clearance phase of hepatitis B virus chronic infection. Molecular Medicine Reports. 11(5). 3465–3472. 22 indexed citations
17.
Zheng, Qi, Youbin Wang, Xiao Long, et al.. (2012). “X”-Shaped Incision and Keloid Skin-Flap Resurfacing: A New Surgical Method for Auricle Keloid Excision and Reconstruction. Dermatologic Surgery. 38(8). 1378–1382. 7 indexed citations
18.
Zhou, Yan, Wendan Yu, Qi Zheng, Yi Xin, & Yufang Ma. (2012). Identification of amino acids involved in catalytic process of M. tuberculosis GlmU acetyltransferase. Glycoconjugate Journal. 29(5-6). 297–303. 6 indexed citations
19.
Adelman, Ron A., Qi Zheng, & Hylton R. Mayer. (2010). Persistent Ocular Hypertension Following Intravitreal Bevacizumab and Ranibizumab Injections. Journal of Ocular Pharmacology and Therapeutics. 26(1). 105–110. 143 indexed citations
20.
Guo, Minggao, Bin Kang, Qi Zheng, et al.. (2009). An anti-preS2 antibody protects human hepatocytes from hepatitis B virus infection.. PubMed. 72(3). 306–11. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026